GL1X · GenesisL1 explorer

MolNFT v1 · #182217 · protein

Human leukocyte antigen A*0201 in complex with SARS-cov-2 epitope ylqprtfll

7MKB · MHC class I antigen: “Human leukocyte antigen A*0201 in complex with SARS-cov-2 epitope ylqprtfll”. X-ray diffraction, 3 pockets (best druggability 0.68). MolNFT v1 #182217 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
7MKB
Type
protein
Length
383 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
MHC class I antigen; Beta-2-microglobulin; Spike protein S1
UniProt
U5YJM1, P61769, P0DTC2
Pockets
3 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 20% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMHC class I antigenprotein27428% helix, 39% strandU5YJM1
BBeta-2-microglobulinprotein1000% helix, 49% strandP61769
CSpike protein S1protein90% helix, 0% strandP0DTC2

Ligands and binding sites

  • GOL · Glycerol · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15940.680.7859GOL
21520.440.7629GOL
3540.280.7517empty

Interfaces

2 interfaces between chains.

  • A–B · 1440 Ų buried · 25 hydrogen bonds · protein-protein
  • A–C · 940 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 7MKB · Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL · the same entry in another collection · chain A against A, TM-score 1.00
  • P61769 · AlphaFold monomer V2.0 prediction for beta-2-microglobulin (P61769) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.